CALIFIA BIO

• August 15, 2011: Califia Bio has been awarded a $218,000 NIH SBIR grant to identify drug-like small molecule mimetics of GRK2ct, which act by modulation of G-protein signaling, for treatment of heart failure. This work will be conducted in collaboration with Dr. Alan Smrcka's research group at the university of Rochester.
• January 31, 2011 Califia Bio Phase 1 SBIR Grant for “Selectively Non-Selective” Kinase Inhibitors for Treatment of HIV Induced Synaptodendritic Damage
• November 1, 2010 Califia Bio Receives $244,479 Qualifying Therapeutic Discovery Grant for Discovery of Novel Therapeutics for the Treatment of HIV-associated Neurological Disease
• October 15, 2010 Califia Bio Subaward for Crestone Inc. Anti-Infectives SBIR Grant
• October 7, 2010: NIH extends grant funding for NeuroAids URMC /Califia Bio Collaboration for five additional years
• September 1, 2010; Califia Bio Participating in Juvenile Diabetes Research Foundation Grant to discover treatments for Diabetic Neuropathy
• December 23, 2008: Califia Bio and University of Rochester Medical Center NIH funded collaboration on Neuro Aids